[1] |
刘兴会. 产后出血预防与处理指南(2014)[J]. 中华妇产科杂志,2014,49(9):641-646.
|
[2] |
American College of Obstetricians and Gynecologists. Practice Bulletin No. 183: Postpartum Hemorrhage[J]. Obstet Gynecol, 2017,130(4):e168-e186.
|
[3] |
Woman Trial Collaborators. Effect of early tranexamic acid administration on mortality, hysterectomy, and other morbidities in women with post-partum haemorrhage (WOMAN): an international, randomised, double-blind, placebo-controlled trial [J]. Lancet, 2017,389(10084):2105-2116.
|
[4] |
Cannon JW. Hemorrhagic Shock[J]. N Engl J Med, 2018,378(4):370-379.
|
[5] |
Kozek-Langenecker SA, Ahmed AB, Afshari A, et al. Management of severe perioperative bleeding: guidelines from the European Society of Anaesthesiology: First update 2016[J]. Eur J Anaesthesiol, 2017,34(6):332-395.
|
[6] |
De Robertis E, Kozek-Langenecker SA, Tufano R, et al. Coagulopathy induced by acidosis, hypothermia and hypocalcaemia in severe bleeding [J]. Minerva Anestesiol, 2015,81(1):65-75.
|
[7] |
Muñoz M, Stensballe J, Ducloy-Bouthors AS, et al. Patient blood management in obstetrics: prevention and treatment of postpartum haemorrhage. A NATA consensus statement[J]. Blood Transfus, 2019,17(2):112-136.
|
[8] |
Mavrides E, Allard S, Chandraharan E, et al. Prevention and Management of Postpartum Haemorrhage: Green-top Guideline No.52[J]. BJOG, 2017,124(5):e106-e149.
|
[9] |
Queensland Clinical Guidelines. Postpartum haemorrhage Guideline No.MN18.1-V10-R23 Primary postpartum haemorrhage. Queensland Health. 2021.
URL
|
[10] |
World Health Organization. WHO Recommendations for the Prevention and Treatment of Postpartum Haemorrhage, Geneva: WHO,2012.ISBN-13: 978-92-4-154850-2.
|
[11] |
刘兴会,陈锰. 基于大数据的产后出血临床处理[J]. 中国实用妇科与产科杂志,2018,34(1): 33-37.
|
[12] |
Elagamy A, Abdelaziz A, Ellaithy M. The use of cell salvage in women undergoing cesarean hysterectomy for abnormal placentation [J]. Int J Obstet Anesth, 2013,22(4):289-293.
|
[13] |
Milne ME, Yazer MH, Waters JH. Red blood cell salvage during obstetric hemorrhage[J]. Obstet Gynecol, 2015,125(4):919-923.
|
[14] |
Ho KM, Leonard AD. Concentration-dependent effect of hypocalcaemia on mortality of patients with critical bleeding requiring massive transfusion: a cohort study[J]. Anaesth Intensive Care, 2011,39(1):46-54.
|
[15] |
Collis RE, Collins PW. Haemostatic management of obstetric haemorrhage[J]. Anaesthesia, 2015,70(Suppl 1):78-86.
|
[16] |
Levi M. Pathogenesis and management of peripartum coagulopathic calamities (disseminated intravascular coagulation and amniotic fluid embolism)[J]. Thromb Res, 2013,131(Suppl 1):S32-S34.
|
[17] |
Shields LE, Smalarz K, Reffigee L, et al. Comprehensive maternal hemorrhage protocols improve patient safety and reduce utilization of blood products[J]. Am J Obstet Gynecol, 2011,205(4):368.e1-8.
|
[18] |
Treml AB, Gorlin JB, Dutton RP, et al. Massive Transfusion Protocols: A Survey of Academic Medical Centers in the United States [J]. Anesth Analg, 2017,124(1):277-281.
|
[19] |
O′brien KL, Shainker SA, Lockhart EL. Transfusion Management of Obstetric Hemorrhage[J]. Transfus Med Rev,2018,32(4):249-255.
|